| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064816 TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE |
| 03/14/2013 | US20130064814 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells |
| 03/14/2013 | US20130064788 Il-17 family cytokine compositions and uses |
| 03/14/2013 | US20130064787 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 03/14/2013 | US20130064763 Anti-icam-1 single domain antibody and uses thereof |
| 03/14/2013 | US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2848074A1 Anti-siglec-15 antibodies and uses thereof |
| 03/14/2013 | CA2847824A1 Caninised antibodies and method for the production of same |
| 03/13/2013 | EP2568049A1 Mice expressing an immunoglobulin hybrid light chain with a human variable region |
| 03/13/2013 | EP2567982A1 Antibody against carcinoembryonic antigen and uses thereof |
| 03/13/2013 | EP2567981A2 Anti-glycoprotein VI SCFV fragment for treatment of thrombosis |
| 03/13/2013 | EP2567980A1 Use of neutralizing prolactin receptor antibodies for inhibition of lactation |
| 03/13/2013 | EP2567979A1 Use of neutralizing prolactin receptor antibodies for the treatment of hyper- and normoprolactinemic hair loss |
| 03/13/2013 | EP2567978A1 Use of neutralizing prolactin receptor antibodies for contraception |
| 03/13/2013 | EP2567977A1 Use of neutralizing prolactin receptor antibodies for the treatment of benign breast disease and mastalgia |
| 03/13/2013 | EP2567976A2 Antibodies against CD38 for treatment of multiple myeloma |
| 03/13/2013 | EP2567975A2 Modulation of RHAMM (CD168) for selective adipose tissue development |
| 03/13/2013 | EP2567973A2 IL-21 antagonists |
| 03/13/2013 | EP2567972A1 Antibodies against E7 protein of Human Papilloma Virus (HPV) |
| 03/13/2013 | EP2567709A2 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
| 03/13/2013 | EP2567234A1 Diagnostic method for the detection of cells ex vivo |
| 03/13/2013 | EP2566895A2 Anti-erbb3 antibodies |
| 03/13/2013 | EP2566894A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
| 03/13/2013 | EP2566893A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/13/2013 | EP2566892A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies |
| 03/13/2013 | EP2566891A2 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 03/13/2013 | EP2566890A2 Anti-pai-1 antibodies and methods of use thereof |
| 03/13/2013 | EP2566889A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/13/2013 | EP2566879A1 Method of functionalizing human red blood cells with antibody |
| 03/13/2013 | EP2566521A2 Immunogen adherence and method of making and using same |
| 03/13/2013 | EP2566520A1 Methods for the treatment of il-1 related conditions |
| 03/13/2013 | EP2566519A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 03/13/2013 | EP2566518A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells |
| 03/13/2013 | EP2566517A2 Antibodies that bind csf1r |
| 03/13/2013 | EP2566511A2 Use of an anti-cd71 antibody for preparing a medicament |
| 03/13/2013 | EP2566510A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations |
| 03/13/2013 | EP2566509A1 Novel antibody to a carbonic anhydrase |
| 03/13/2013 | EP2566503A1 Therapeutic peptide composition and method |
| 03/13/2013 | EP2566495A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| 03/13/2013 | EP1962903B1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or fltl antagonist for treating cancer |
| 03/13/2013 | EP1392359B2 Specific binding proteins and uses thereof |
| 03/13/2013 | CN1984672B Modulation of NKG2D |
| 03/13/2013 | CN102971343A Novel antibody for the diagnosis and/or prognosis of cancer |
| 03/13/2013 | CN102971342A Novel lowered affinity antibodies and methods of marking the same |
| 03/13/2013 | CN102971341A Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine IL-23 |
| 03/13/2013 | CN102971340A Antibodies with enhanced or suppressed effector function |
| 03/13/2013 | CN102971339A Histone citrullinated peptides and uses thereof |
| 03/13/2013 | CN102970975A Method for preparing an enriched IgG composition from plasma |
| 03/13/2013 | CN102967712A ELISA (Enzyme Linked Immunosorbent Assay) kit for qualitative and quantitative detection of walnut protein and detection method of kit |
| 03/13/2013 | CN102967710A Competitive ELISA kit for peste-des-petits-ruminants antibody detection and preparation method thereof |
| 03/13/2013 | CN102967703A Biologically safe Africa swine fever antigen multifactorial serum for ELISA diagnosis |
| 03/13/2013 | CN102965379A Soluble tumor necrosis factor related apoptosis-inducing ligand gene and protein of hyriopsis cumingii and preparation method of antibody |
| 03/13/2013 | CN102965348A Bovine viral diarrhea-mucosal virus with modified erns protein |
| 03/13/2013 | CN102965343A Hybridoma cell strain secreting bovine gamma-interferon monoclonal antibody, monoclonal antibody thereof and application of monoclonal antibody |
| 03/13/2013 | CN102964449A Recombinant anti-human CD25 chimeric antibody |
| 03/13/2013 | CN102964448A Preparation method of trimeresurus albolabris poison-resistant egg yolk antibody |
| 03/13/2013 | CN102964447A Cry1Ab/Ac genetically modified ingredient paired monoclonal antibody preparation and detection method |
| 03/13/2013 | CN102961746A Use of tnf inhibitor for treatment of erosive polyarthritis |
| 03/13/2013 | CN102690787B Hybridoma cells capable of secreting an anti human [beta]-actin protein monoclonal antibody and preparation method thereof |
| 03/13/2013 | CN102399751B Anti-mycobacterium tuberculosis monoclonal antibody, epitope recognized by anti-mycobacterium tuberculosis monoclonal antibody, and use thereof |
| 03/13/2013 | CN102363768B Monoclonal antibody hybridoma cell lines of soybean lipoxygenase isozyme, and antibody and application thereof |
| 03/13/2013 | CN101985472B Monoclonal antibody TBCD6 resistant to mycobacterium tuberculosis CFP-10 and application |
| 03/13/2013 | CN101768214B Human tumor marker-Tim17 polypeptide and application thereof |
| 03/13/2013 | CN101492507B Complex of Fab fragment of C2H7 and CD20 antigen epitope polypeptide |
| 03/13/2013 | CN101405030B Use of an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 in preparing kit for tumor therapy |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/13/2013 | CN101048659B Monoclonal antibodies to progastrin |
| 03/13/2013 | CN101001873B Variant fc regions |
| 03/12/2013 | US8394939 Nucleic acid encoding fused |
| 03/12/2013 | US8394932 Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394925 Fc variants with altered binding to FcRn |
| 03/12/2013 | US8394924 Directed engagement of activating Fc receptors |
| 03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
| 03/12/2013 | US8394764 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | US8394390 Neisserial antigenic peptides |
| 03/12/2013 | US8394382 Siglec-9 Binding Agents |
| 03/12/2013 | US8394381 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 03/12/2013 | US8394378 Antibodies binding human collagen II |
| 03/12/2013 | US8394368 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 03/12/2013 | CA2676185C Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 03/12/2013 | CA2576953C Polypeptide having activity of unsaturating omega 3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 03/12/2013 | CA2506724C Antibodies, polypeptides and uses thereof |
| 03/12/2013 | CA2497744C Antibody against secreted n-terminal peptide of gpc3 present in blood or c-terminal peptide of gpc3 |
| 03/12/2013 | CA2492631C Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2461714C Treatment of chronic joint inflammation |
| 03/12/2013 | CA2416877C Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
| 03/12/2013 | CA2380443C Single-domain antigen-binding antibody fragments derived from llama antibodies |
| 03/12/2013 | CA2354599C Binding molecules for human factor viii and factor viii-like proteins |
| 03/12/2013 | CA2288218C Novel differentiation-inhibitor |
| 03/08/2013 | CA2845395A1 Antibody against colorectal cancer marker |
| 03/07/2013 | WO2013033517A1 Viral clearance methods |